Company intelligence

TELA

TELA Bio, Inc. · NASDAQ · Healthcare

Price$1.01-7.76% · −$0.09

Market cap45.59MEquity value

P / E-1.3Trailing ratio

Volume267.75KLatest session

Market data

TELA price chart

TradingView

Related signals

1 min delayed

Browse public TELA signals with their source context and measured market impact. Open any signal for its permanent analysis page.

TELAMar 25, 2026+8.11% since signal

TELA Bio's Q4 Sales Miss and Lowered Q1 Expectations Dampen Sentiment

TELA Bio reported mixed fourth-quarter results with losses better than expected, but sales missed estimates, leading to lowered first-quarter projections. Analysts have subsequently lowered their price targets, reflecting heightened caution around TELA's near-term performance, which could impact investor confidence and stock valuation.

View signal analysis

TELANov 14, 2025+25.00% since signal

These Analysts Cut Their Forecasts On TELA Bio After Q3 Earnings

TELA reported Q3 losses of 19 cents, better than expected. Quarterly sales of $20.7 million missed analysts' expectations. CEO claims progress from improved leadership and strategic changes. Shares fell 13.7% post-earnings to $0.96. Analysts adjusted price targets downward; mixed ratings issued.

View signal analysis

Research